Leerink analyst Asthika Goonewardene assumes coverage on Kura Oncology (NASDAQ: KURA) with a Outperform rating and a price target of $21.00.

For an analyst ratings summary and ratings history on Kura Oncology click here. For more ratings news on Kura Oncology click here.

Shares of Kura Oncology closed at $10.68 yesterday.